Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
---|---|---|---|---|---|---|
BHVN | Biohaven Ltd. | Chief Executive Officer, Director | $123M | +$6M | +5.14% | Jan 5, 2025 |
RVNC | Revance Therapeutics, Inc. | Director | $0 | Feb 4, 2025 | ||
BHVN | Biohaven Pharmaceutical Holding Co Ltd. | Chief Executive Officer, Director | Oct 3, 2022 | |||
AKLI | Akili, Inc. | Director | Jun 29, 2021 |
Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
---|